aspergillosis
Powerful Antifungal Agent Approved for Pediatric Patients
Although rare, invasive aspergillosis and invasive mucormycosis pose a lethal threat to immunocompromised children.
MARCH 13, 2024
COVID-19–Associated Aspergillosis: A New Threat
COVID-19–associated invasive pulmonary aspergillosis (CAPA) is a new entity affecting critically ill COVID-19 ...
NOVEMBER 25, 2020
Load more